维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Michelle PK"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Ranibizumab versus verteporfin photodynamic therapy for neovascular age- related macular degeneration: two-year results of the ANCHOR study 显示文摘	Brown DM Michels M Kaiser PK	2009	Ophthalmology2009，116，1：	1
2	Ranibizumab versus verteporfin for neovascuIar age-related macular degeneration 显示文摘	BROWN DM KAISER PK MICHELS M	2006	N Engl J Med2006，355，14：	1
3	Ranibizumab versus verteporfin for neovascular age-related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M	2006	N Engl J Med2006，355，14：	1
4	Ranibizumab versus verteporfin photodynamic therapy for neovascular age- related macular degeneration: Two-year results of the ANCHOR study 显示文摘	Brown DM Kaiser PK Michels M	2009	Ophthalmology2009，116，1：	1
5	Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration:Two-year results of the ANCHOR study显示文摘	Brown DM Michels M Kaiser PK	2009	Ophthalmology2009，116，：	1
6	Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study 显示文摘	Brown DM Michels M Kaiser PK	2009	Ophthalmology2009，116，1：	1
7	Ranibizumab versus VerteporfinPhotodynamic Therapy for Neovascular Age-Related Macular Degeneration:2-Year显示文摘	Brown DM Michels M Kaiser PK	2009	Results of ANCHOR Study Ophthalmol2009，116，：	1
8	Ranibizumab versus verteporfin for neovascular age- related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M Soubrane G Heier JS Kim RY	2006	N Engl J Med2006，355，14：	1
9	Ranibizumab versus verteporfin for neovascular age-related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M	2006	N Engl J Med2006，355，14：	1
10	Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities显示文摘	Donald SC Colin FLA Michelle PK	2009	Am Heart J2009，158，：	1
11	Ranibizumab versus verteporfm for neovascular age- related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M Soubrane G Heier JS Kim RY	2005	N Engl J Med2005，355，14：	1
12	Ranibizumab versus verteporfin for neovascular age - related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M Soubrane G Heier JS Kim RY Sy JP Schneider S: ANCHOR Study Croup	2006	N Engl Med2006，355，14：	1
13	Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study 显示文摘	Brown DM Michels M Kaiser PK	2009	Ophthalmology2009，116，1：	1
14	Ranibizumab versus verteporfm photodynamic therapy for neovascular age-related macular degeneration:Two-year re- sults of the ANCHOR study 显示文摘	BROWN DM MICHELS M KAISER PK HEIER JS SY JP	2009	Ophthalmology2009，，：	1
15	Ranibizumab versus verteporfin for neovascular age related macular degeneration显示文摘	Brown DM Kaiser PK Michels M	2006	N Ensl J Med2006，355，：	1
16	Ranibizumab versus verteporfin for neovascular age-related macular degeneration显示文摘	Brown DM Kaiser PK Michels M Boubrane G Heier JS Kim RY	2006	N Engl J Med2006，355，14：	1
17	Ranibizumab versus verteporfin for neovascular age-related macular degeneration显示文摘	Brown DM Kaiser PK Michels M	2006	N Engl J Med2006，355，14：	1
18	Ranibizumab versusverteporfin photodynamic therapy for neovascular age-related maculardegeneration: two-year results of the ANCHOR study 显示文摘	Brown DM Michels M Kaiser PK	2009	Ophthalmology2009，116，1：	1
19	Ranibizumab versus verteporfin for neovascular age-related maeular degeneration 显示文摘	Brown DM Kaiser PK Michels M	2006	N EnglJ Me2006，355，14：	1
20	Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration 显示文摘	Brown DM Kaiser PK Michels M Soubrane G Heier JS Kim RY	2005	N Engl J Med2005，355，14：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示